10,000 results
·
43ms
·
Sources: EU EUDAMED, US FDA
Progensa
FDA UDI
Hologic, Inc.·15420045500747·
Progensa
FDA UDI
Hologic, Inc.·15420045500792·
Progensa
FDA UDI
Hologic, Inc.·15420045500754·
Progensa
FDA UDI
Hologic, Inc.·15420045500730·
Progensa
FDA UDI
Hologic, Inc.·15420045500808·
Progensa
FDA UDI
Hologic, Inc.·15420045500815·
Progensa
FDA UDI
Hologic, Inc.·15420045500822·
Progensa
FDA UDI
Hologic, Inc.·15420045500761·
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·PROGENSA PCA3 ASSAY
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·Progensa PCA3 Assay
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·PROGENSA PCA3 ASSAY
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·PROGENSA PCA3 ASSAY
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·Progensa PCA3 Assay
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·PROGENSA PCA3 ASSAY
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·PROGENSA PCA3 ASSAY
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·PROGENSA PCA3 ASSAY
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·Progensa PCA3 Assay
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·Progensa PCA3 Assay
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·Progensa PCA3 Assay
Prostrate Cancer Genes Nucleic Acid Amplification Test System
FDA Pre-Market Approval
FDA Class 3
·Progensa PCA3 Assay